Open Accessβ‑catenin inhibitors ICG‑001 and pyrvinium sensitize bortezomib‑resistant multiple myeloma cells to bortezomib
Author(s) -
Cuicui Wu
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13326
Subject(s) - bortezomib , apoptosis , wnt signaling pathway , flow cytometry , viability assay , cell culture , medicine , catenin , cancer research , cell , cell cycle , chemistry , multiple myeloma , pharmacology , signal transduction , biology , immunology , biochemistry , genetics